Application of molecular epidemiology to lung cancer chemoprevention

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 63-68

  Mooney, LaVerne A ^a   Perera, Frederica P ^a  

^a Div of Environ Health Sciences ^*  (United States)

Author keywords

antioxidants; chemoprevention; DNA damage; genotype; lung cancer

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; RETINOL; TUMOR MARKER; VITAMIN; ZEAXANTHIN; ANTINEOPLASTIC AGENT; BENZO[A]PYRENE; CARCINOGEN; DNA;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CHEMOPROPHYLAXIS; DNA DAMAGE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; VITAMIN INTAKE; BIOLOGICAL MODEL; CLINICAL TRIAL; DISEASE PREDISPOSITION; EPIDEMIOLOGY; GENETICS; LUNG TUMOR; METABOLISM; METHODOLOGY; REVIEW; RISK FACTOR; SMOKING;

ANTICARCINOGENIC AGENTS; BENZO(A)PYRENE; CARCINOGENS; CLINICAL TRIALS; DISEASE SUSCEPTIBILITY; DNA; EPIDEMIOLOGY, MOLECULAR; HUMANS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 0030329379     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1996)25+<63::AID-JCB9>3.0.CO;2-0     Document Type: Article

References (33)

1. Schulte PA, Perera FP (eds) (1993): "Molecular Epidemiology: Principles and Practices." New York: Academic Press.
2. Perera FP: Molecular cancer epidemiology (1987): A new tool in cancer prevention. J Natl Cancer Inst 78:887-898.
3. Hulka BS (1991): Epidemiological studies using biological markers: Issues for epidemiologists. Cancer Epidemiol Biomarkers Prev 1:13-19.
4. Perera FP, Mooney LA (1993): The role of molecular epidemiology in cancer prevention. In DeVita VT, Hellman S, Rosenberg SA (eds): "Cancer Prevention." Philadelphia: J B. Lippincott, pp 1-15.
5. Harris C (1991): Chemical and physical carcinogenesis: Advances and perspectives for the 1990s. Cancer Res 51 (Suppl):5023S-5044S.
6. Guidotti TL (1992): Hidden assumptions in environmental research. Environ Res 59:101-113.
7. Benner SE, Pastorino U, Lippman SM, Hong WK (1994): Second international cancer chemoprevention conference. Cancer Res 54:854-856.
8. Kelloff GJ, Malone WF, Boone CW, Steele VE, Doody LA (1992): Intermediate biomarkers of precancer and their application in chemoprevention. J Cell Biochem 16G (Suppl):15-21.
9. Greenwald P, Nixon DW, Malone WF, Kelloff GJ, Stern HR, Witkin KM (1990): Concepts in cancer chemoprevention research. Cancer 65:1483-1490.
10. Doll R, Peto R (1981): "The Causes of Cancer: Quantitative Estimates of Avoidable Risk of Cancer in the United States Today." New York: Oxford University Press, pp 1220-1224.
11. ACS (1994): "Cancer Facts and Figures - 1994." Atlanta: American Cancer Society.
12. Villeneuve PJ, Mao Y (1994): Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health 85:385-388.
13. Vineis P, Caporaso N (1995): Tobacco and cancer: Epidemiology and the laboratory. Environ Health Perspect 103:156-160.
14. Marshall CJ (1991): Tumor suppressor genes. Cell 64: 313-326.
15. Li FP (1990): Familial cancer syndromes and clusters. Curr Probl Cancer 49:75-113.
16. Vahakangas K, Pelkonen O (1989): Host variations in carcinogen metabolism and DNA repair. In Lynch HT, Hirayama T (eds): "Genetic Epidemiology of Cancer." Boca Raton: CRC Press, pp 35-54.
17. Hayashi S, Watanabe J, Kawajiri K (1992): High susceptibility to lung cancer analyzed in terms of combined genotype of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866-870.
18. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K (1991): Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51:5177-5180.
19. Hamada GS, Sugimura H, Suzuki I, Nagura K, Kiyokawa E, Iwase T, Tanaka M, Takahashi T, Watanabe S, Kino I, Tsugane S (1995): The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the Rsal polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarkers Prev 4:63-67.
20. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ (1994): Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15:2961-2963.
21. McWilliams JE, Sanderson BJS, Harris EL, Richert-Boe KE, Henner WD (1995): Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4:589-594.
22. Cohen L (1987): Diet and cancer. Sci Am 257:42-48.
23. Willett WC (1990): Vitamin A and lung cancer. Nutr Rev 48:201-211.
24. Block G (1992): The data support a role for antioxidants in reducing cancer risk. Nutr Rev 50:207-213.
25. Patent ER, Kaseki H, Mohammed JR, Cornwell DG, Davis WB (1986): Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxity. J Clin Invest 77:789-796.
26. Frei B, Forte TM, Aines BN, Cross CE (1991): Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem J 277:133-138.
27. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A (1993): Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 53:3486-3492.
28. Tang D, Santella RM, Blackwood A, Young T-L, Mayer J, Jaretzki A, Grantham S, Carberry D, Steinglass KM, Tsai W-Y, Perera FP (1995): A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol Biomarkers Prev 4:341-346.
29. Grinberg Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW, Santella RM (1994): Polycyclic aromatic hydrocarbon - DNA adducts in smokers and their relationship to micronutrient levels and glutatione-S-transferase M1 genotype. Carcinogenesis 15:2449-2454.
30. Freedman LS, Schatzkin A, Schiffman MH (1992): Statistical validation of intermediate markers of precancer for use as endpoints in chemoprevention trials. J Cell Biochem 16G (Suppl):27-32.
31. Benner SE, Hong WK, Lippman SM, Lee JS, Hittelman WM (1992): Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials. J Cell Biochem 16G (Suppl):33-38.
32. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991): p53 Mutations in human cancers. Science 253: 49-53.
33. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, Ueda R (1992): p53 Mutations in non-small cell lung cancer in Japan: Association between mutations and smoking. Cancer Res 52:734-736.